Literature DB >> 22431077

Sensory Guillain-Barré syndrome and related disorders: an attempt at systematization.

Antonino Uncini1, Nobuhiro Yuki.   

Abstract

The possibility that some patients diagnosed with an acute sensory neuropathy could actually have Guillain-Barré syndrome (GBS) has been repeatedly advanced in the literature, but the number of cases reported is small. The reports have shown different clinical presentations and electrophysiological findings and are variously named, thus generating terminological and nosological confusion. We operatively defined sensory GBS as an acute, monophasic, widespread neuropathy characterized clinically by exclusive sensory symptoms and signs that reach their nadir in a maximum of 6 weeks without related systemic disorders and other diseases or conditions. We reviewed the literature through searches of PubMed from 1980 to March 2011 and our own files. On the basis of the size of fibers involved and the possible site of primary damage, we propose tentatively classifying sensory GBS and related disorders into three subtypes: acute sensory demyelinating polyneuropathy; acute sensory large-fiber axonopathy-ganglionopathy; and acute sensory small-fiber neuropathy-ganglionopathy.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22431077     DOI: 10.1002/mus.22298

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  10 in total

1.  Unusual sensory variant of Guillain-Barré syndrome.

Authors:  Milena Semproni; Gillian Gibson; Laura Kuyper; Penny Tam
Journal:  BMJ Case Rep       Date:  2017-07-14

Review 2.  Acquired neuropathies.

Authors:  Pierre Lozeron; Jean-Marc Trocello; Nathalie Kubis
Journal:  J Neurol       Date:  2013-06-16       Impact factor: 4.849

3.  Sensory Predominant Guillain-Barré Syndrome Concomitant with Dengue Infection: A Case Report.

Authors:  Alvin Oliver Payus; Azliza Ibrahim; Constance Liew Sat Lin; Tan Hui Jan
Journal:  Case Rep Neurol       Date:  2022-06-17

4.  Comment on "SARS-CoV-2 vaccinations may not only be complicated by GBS but also by distal small fiber neuropathy by J. Finsterer.

Authors:  Giuliana Galassi
Journal:  J Neuroimmunol       Date:  2022-06-01       Impact factor: 3.221

Review 5.  Diagnostic insights into chronic-inflammatory demyelinating polyneuropathies.

Authors:  Johannes J Roggenbuck; Joseph Boucraut; Emilien Delmont; Karsten Conrad; Dirk Roggenbuck
Journal:  Ann Transl Med       Date:  2018-09

6.  Sensory Guillain-Barré syndrome: A case report.

Authors:  Jing Zhang; Na Liu; Zhe-Cheng Zhang; Rui-Zhi Zheng; Qian Li
Journal:  Exp Ther Med       Date:  2014-09-30       Impact factor: 2.447

Review 7.  Diagnosis and management of Guillain-Barré syndrome in ten steps.

Authors:  Sonja E Leonhard; Melissa R Mandarakas; Francisco A A Gondim; Kathleen Bateman; Maria L B Ferreira; David R Cornblath; Pieter A van Doorn; Mario E Dourado; Richard A C Hughes; Badrul Islam; Susumu Kusunoki; Carlos A Pardo; Ricardo Reisin; James J Sejvar; Nortina Shahrizaila; Cristiane Soares; Thirugnanam Umapathi; Yuzhong Wang; Eppie M Yiu; Hugh J Willison; Bart C Jacobs
Journal:  Nat Rev Neurol       Date:  2019-09-20       Impact factor: 42.937

8.  Atypical Guillain-Barre syndrome with T6 sensory level.

Authors:  Osamah Al-Ameen; Mohanad Faisal; Salma Mustafa; Mohammed Alhatou
Journal:  Clin Case Rep       Date:  2022-10-08

Review 9.  Guillain-Barré and Miller Fisher syndromes--new diagnostic classification.

Authors:  Benjamin R Wakerley; Antonino Uncini; Nobuhiro Yuki
Journal:  Nat Rev Neurol       Date:  2014-07-29       Impact factor: 42.937

Review 10.  Autoimmune Peripheral Neuropathies and Contribution of Antiganglioside/Sulphatide Autoantibody Testing.

Authors:  Dirk Roggenbuck; Emilien Delmont; Dirk Reinhold; Peter Schierack; Karsten Conrad; Joseph Boucraut
Journal:  Mediterr J Rheumatol       Date:  2020-03-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.